Medullary thyroid cancer other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by one other user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{Ammu}}
{{CMG}}; {{AE}} {{Ammu}}
==Overview==
==Overview==
Other diagnostic studies for medullary thyroid cancer include nuclear imaging, which demonstrates increased uptake of radioactive iodine at the areas of [[metastases]].
Other diagnostic studies for medullary thyroid cancer include nuclear imaging, which demonstrates increased uptake of [[radioactive]] [[iodine]] at the areas of [[metastases]].
==Key Findings in Nuclear Imaging in Medullary Thyroid Cancer==
==Other Diagnostic Studies==
* Radioactive iodine
* Key findings in nuclear imaging in medullary thyroid cancer are:<ref>Thyroid Cancer Cancer.gov (2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#link/stoc_h2_2- Accessed on October, 29 2015</ref>
* Increased uptake of radioactive iodine at the areas of [[metastases]]
* FDG-PET: avid uptake
* FDG-PET: avid uptake
* Tl-201: It has been shown to concentrate Thallium
* Tl-201: It has been shown to concentrate Thallium
* I-123 MIBG: 30% of MTCs show uptake if the thyroid is blocked with Lugol solution prior to the scan<ref>Thyroid Cancer  Cancer.gov (2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#link/stoc_h2_2- Accessed on October, 29 2015</ref>
* I-123 MIBG: 30% of medullary thyroid cancer show uptake if the thyroid is blocked with Lugol solution prior to the scan
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Endocrine system]]
[[Category:Endocrine system]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]

Latest revision as of 14:29, 14 October 2019

Medullary thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Medullary thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Medullary thyroid cancer other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Medullary thyroid cancer other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Medullary thyroid cancer other diagnostic studies

CDC on Medullary thyroid cancer other diagnostic studies

Medullary thyroid cancer other diagnostic studies in the news

Blogs on Medullary thyroid cancer other diagnostic studies

Directions to Hospitals Treating Medullary thyroid cancer

Risk calculators and risk factors for Medullary thyroid cancer other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Other diagnostic studies for medullary thyroid cancer include nuclear imaging, which demonstrates increased uptake of radioactive iodine at the areas of metastases.

Other Diagnostic Studies

  • Key findings in nuclear imaging in medullary thyroid cancer are:[1]
  • Increased uptake of radioactive iodine at the areas of metastases
  • FDG-PET: avid uptake
  • Tl-201: It has been shown to concentrate Thallium
  • I-123 MIBG: 30% of medullary thyroid cancer show uptake if the thyroid is blocked with Lugol solution prior to the scan

References

  1. Thyroid Cancer Cancer.gov (2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#link/stoc_h2_2- Accessed on October, 29 2015


Template:WikiDoc Sources